Equity
€50,787 from €377,921 in 2021
Equity fell by 87% in 4 years.
ALPHADERM
Lifetime
7 annual accounts with figures on one time axispeak €244,827 (2025)
€244,827▲ 37.0%
lowest -€75,015 (2019)
-€914▲ €27,223
peak €377,921 (2021)
€50,787▼ 1.8%
€1.2m▲ 2.8%
peak 1.6 FTE (2020)
-not published
Board3 names since 2019
3 directorsDE PAUW Eva Esther Ann and 2 others
Documentsfilings and deeds
18-06-202643 days before the deadline
2025micro format
Gross margin from €178,751 to €244,827Loss of €914Cash from €34,042 to €11,380
Key points
from the 2025 annual accountsLosses
-€51,154 in three years
Every financial year from 2023 to 2025 closed with a loss. 2024 was the heaviest.
Turnover
≈ €440,000 estimated
The micro format states no turnover.
Debts
€1.2m 96% of the balance sheet
Financial debts 52%Suppliers 11%Taxes and wages 3%Other 35%
Of this, €630,400 falls due within a year.
Filings
7 annual accounts since 2019
The last five annual accounts were filed 11 to 48 days before the end of the period.
Position in the sector
€244,827
Higher gross margin than 92% of companies in personal services. Sector median €26,934 · 5,753 companies.
Checked score
79
Excellent
Financially stronger than 30% of micro companies in personal services (NACE 96)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.7% across 7,626 companies (NACE 96, micro).
About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 1.2%
01-2025: 1.2%● unchanged vs 12-2024
02-2025: 1.2%● unchanged vs 01-2025
03-2025: 1.2%● unchanged vs 02-2025
04-2025: 1.3%▲ +0.1 percentage points vs 03-2025
05-2025: 1.8%▲ +0.5 percentage points vs 04-2025
06-2025: 2.0%▲ +0.2 percentage points vs 05-2025
07-2025: 2.1%▲ +0.1 percentage points vs 06-2025highest value
08-2025: 1.1%▼ -1.0 percentage point vs 07-2025
09-2025: 1.2%▲ +0.1 percentage points vs 08-2025
10-2025: 1.2%● unchanged vs 09-2025
11-2025: 1.0%▼ -0.2 percentage points vs 10-2025
12-2025: 1.0%● unchanged vs 11-2025
01-2026: 0.9%▼ -0.1 percentage points vs 12-2025
02-2026: 1.0%▲ +0.1 percentage points vs 01-2026
03-2026: 1.0%● unchanged vs 02-2026
04-2026: 1.1%▲ +0.1 percentage points vs 03-2026
05-2026: 1.5%▲ +0.4 percentage points vs 04-2026
06-2026: 1.6%▲ +0.1 percentage points vs 05-2026
07-2026: 1.1%▼ -0.5 percentage points vs 06-2026
08-2026: 1.1%● unchanged vs 07-2026
09-2026: 1.1%● unchanged vs 08-2026
10-2026: 0.5%▼ -0.6 percentage points vs 09-2026lowest value
11-2026: 0.5%● unchanged vs 10-2026lowest value
Financial strengthWeak
Score breakdown
raises risk
Equity €50,787 (4.2% of total assets)
Founded in 2019
lowers risk
Size: total assets €1.2m
Figures for financial year 2025 (filed on 18-06-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 96, micro). It does better than 32% of them on solvency, 19% on liquidity, 33% on profitability and 37% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 849 companies had the same profile as ALPHADERM has now. Each dot stands for 3 companies, two years later.
91.9%
were still trading
3.3%
stopped another way
4.7%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of ALPHADERM itself is lower: 0.5% within 12 months. It rests on far more data about ALPHADERM than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 849 companies, not a prediction for ALPHADERM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €4,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.48 (0.39 in 2024), below 1. Short-term debt is 51.9% and cash 0.9% of total assets. 95.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
19202122232425
2019 to 2025 · latest year -€914
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
43 days early
2024
29 days early
2023
48 days early
2022
39 days early
2021
11 days early
2020
16 days early
2019
36 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 32 days before the deadline. In the sector (NACE 96), the median for financial year 2024 was on the deadline day, and 48% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 22 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- STAELENS Viviane Yvonne Berthe 12,904 sharesdeed of 22-08-2019
- DE PAUW Jozef Eduard Rachel 12,828 sharesdeed of 22-08-2019
- DE PAUW Sarah Suzanrie Wivina 5 sharesdeed of 22-08-2019
Recent changes
Registered office moved from Oudenaarde to Nukerke
New registered office: Rijksweg 71 te 9681 Nukerke · Previous registered office: Jezuietenplein 14 te 9700 Oudenaarde · Board meeting of 17-03-2024 · Gazette deed
Demerger proposal: ALPHADERM splits off to ALPHA STAY BV
Founding capital of €128,7, 25,742 shares · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0732510346
Amendment of the articles
General meeting of 24-05-2022 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ALPHADERM Maarkedal | €1.2m | €244,827 | 4.2% | - |
| Simply B Oud-Heverlee | €0.9m | €264,453 | 61.9% | - |
| NAILS COMPANY Charleroi | €1.6m | €276,141 | 30.1% | 3.4 |
| Skingenium Meise | €1.0m | €207,556 | 36.0% | - |
| Renatus Oostkamp | €0.9m | €182,267 | 45.8% | - |
| Medicolaser Woluwe-Saint-Lambert | €0.9m | €190,825 | 11.1% | - |
| BROWWAXBAR Wommelgem | €0.8m | €267,969 | 13.8% | - |
These companies have the same main activity as ALPHADERM: beauty care and other beauty treatments (NACE 96220). They are comparable in size and age: total assets between €849,000 and €1.6m, founded between 2017 and 2021.
Official details
Source: KBO- Status
- Active since 29-07-2019Normal situation
- Activity
- Beauty care and other beauty treatmentsNACE 96220and 1 other
- Establishment unit
- 2.292.430.1979681 Maarkedal, since 12-08-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 31-10-2023
Annual accounts 2025
- €1.2m▲ 2.4%
- Employeeson 31-12-2025
- 3=
- Filing
- Filed on 18-06-2026, 43 days before the end of the filing period
Insights on ALPHADERM
ALPHADERM files the micro format. That format states no turnover. The gross margin rose from €104,790 in 2019 to €244,827 in 2025.
The balance sheet grew most in 2023 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ALPHADERM
- What is the company number of ALPHADERM?
- The company number of ALPHADERM is 0732.510.346. The VAT number is the same number with BE in front: BE 0732.510.346.
- Where is ALPHADERM based?
- The registered office is at Rijksweg 71, 9681 Maarkedal.Company details
- What does ALPHADERM do?
- According to the KBO register, the main activity is beauty care and other beauty treatments (NACE 96220).
- What is the legal form of ALPHADERM?
- ALPHADERM is a private limited company (BV).
- When was ALPHADERM founded?
- ALPHADERM was founded on 29-07-2019.
- Is ALPHADERM still active?
- Yes, ALPHADERM is an active enterprise in the KBO register.
- How many employees does ALPHADERM have?
- ALPHADERM had an average of 2.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of ALPHADERM?
- The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €244,827 and 38 comparable companies (NACE 96). It probably lies between €320,000 and €500,000. In financial year 2019 turnover was €485,591.
- Is ALPHADERM profitable?
- In financial year 2025, ALPHADERM made a loss of €914.
- Where can I find the annual accounts of ALPHADERM?
- ALPHADERM filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ALPHADERM due?
- ALPHADERM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.